General MedicationsINJECTIONGeneric

PANTOPRAZOLE SODIUM

Standard Dose

40MG

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: None (Tentative Approval)

Summary

Approval overview PANTOPRAZOLE SODIUM is listed in Drugs@FDA under application 022226 (NDA).

Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient PANTOPRAZOLE SODIUM Form and strength INJECTABLE; INJECTION - 40MG Sponsor TEVA PARENTERAL Submission history Latest submission status date: 2008-10-20 00:00:00.

Structured Monograph

Clinical summary

Approval overview PANTOPRAZOLE SODIUM is listed in Drugs@FDA under application 022226 (NDA). Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient PANTOPRAZOLE SODIUM Form and strength INJECTABLE; INJECTION - 40MG Sponsor TEVA PARENTERAL Submission history Latest submission status date: 2008-10-20 00:00:00. Submission type: ORIG.

Monitoring

• Marketing status: None (Tentative Approval)
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.